WHO halts hydroxychloroquine and combination of HIV drug trials among hospitalised COVID-19 patients

"These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised COVID-19 patients when compared to the standard of care.